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Background
Rapid drug desensitization (DST) protocols have been
developed based on clinical evidence, but in vitro studies
are lacking. Understanding the mechanisms involved in
the early stages of DST will allow improvements in
patients’ treatment. The aim of this study is to demon-
strate and characterize the induction of hyporesponsive-
ness in murine mast cells by desensitization.
Methods
We assessed the effect of rapid desensitization on murine
bone marrow derived mast cells (BMMC). Experiments
with three diferent types of murine BMMC were done:
wild-type, LILRB4-/-, and transgenic expressing the
human receptor FceRI. Wild-type and LILRB4-/- BMMC
were sensitized with anti-DNP IgE and stimulated with
DNP, while transgenic BMMC were sensitized with
concentrated human serum of allergic subjects and sti-
mulated with the respective allergen. BMMC were stimu-
lated through desensitization or single activation, with
optimal or suboptimal doses of antigen. Comparisions
were made according to the percentage of b-Hexosamini-
dase (b-Hex) release by BMMC and the expression of
LAMP-1 on the surface of these cells. Furthermore,
expression of FceRI, PDL1 and LILRB4 on the surface of
BMMC were also assessed.
Results
DST inhibited the IgEmediated degranulation of
BMMCs as desensitized cells released 43.3% less bHex
and showed 73.2% lower LAMP1 surface expression
compared to activated BMMCs. A group of desensitized
and activated BMMCs were challenged again with an
extra dose of 1 ng DNPHAS and additional release of
bHex and LAMP1 expresssion were not different from
the negative control, regardless whether BMMCs had
been previously desensitized or activated. The hypore-
sponsiveness state of BMMCs induced by DST and acti-
vation was not due to mediator depletion as calcium
ionophore induced marked release of bHex in these
cells. Activated and desensitized BMMCs, respectively,
expressed 40.3% and 15.7% less FcεRI, 45.9% and 13.1%
less PDL1, and 23.5% and 11.3% less GP49 than negative
controls. We observed that while the expression of
PDL1 on the cell membrane decreased, its intracellular
amount increased.
Conclusions
Desensitization and activation induced hyporesponsive-
ness in WT and humanized BMMC, which can be
assessed by LAMP1 expression and b-Hex secretion.
Hyporesponsiveness is not due to depletion of mediators
or mediated by soluble factors, and is associated, but not
dependent on FceRI internalization.
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